Search

Your search keyword '"Oldroyd, Keith G."' showing total 858 results

Search Constraints

Start Over You searched for: Author "Oldroyd, Keith G." Remove constraint Author: "Oldroyd, Keith G."
858 results on '"Oldroyd, Keith G."'

Search Results

2. Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)

3. The Index of Microcirculatory Resistance After Primary PCI: A Pooled Analysis of Individual Patient Data

4. Impact of Post-PCI FFR Stratified by Coronary Artery

6. Optimal timing of influenza vaccination among patients with acute myocardial infarction – Findings from the IAMI trial

7. Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial

8. Sex-Specific Clinical Outcomes After Treatment of Left Main Coronary Artery Disease. A NOBLE Substudy

9. A Noncontrast CMR Risk Score for Long-Term Risk Stratification in Reperfused ST-Segment Elevation Myocardial Infarction

10. Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial Infarction

12. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

14. Evaluation and Management of Nonculprit Lesions in STEMI

16. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA)

20. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

21. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial

26. Fractional Flow Reserve-Guided Stent Optimisation in Focal and Diffuse Coronary Artery Disease

30. One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial

31. Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - from the IAMI trial

33. Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment

34. Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction

35. Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction

36. Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders

37. Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: A Pilot Randomized Controlled Trial

39. The pathophysiological role of the endogenous opioid system in myocardial ischaemia and cardiac failure

40. Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors

41. 25 Diagnostic Value of Myocardial Blood Flow Imaging in Patients with Ischaemia and Non-Obstructive Coronary Arteries

42. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial

44. Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study

46. Coronary Artery Perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study

50. Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.

Catalog

Books, media, physical & digital resources